Journal profile · Peripheral Vascular Disease
Journal of Human Hypertension
ISSN 0950-9240 · eISSN 1476-5527 · Springer Nature · ENGLAND · Monthly · Founded 1997
Journal of Human Hypertension: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.28; hybrid open access; APC about USD 4,790; median 129 days to acceptance (105 articles, last 24 months); community-reported acceptance: fairly easy; 126 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Human Hypertension is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention and Heart Rate Variability and Autonomic Control, together about 48.1% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Human Hypertension is published monthly and is of interest to health care professionals who deal with hypertension (specialists, internists, primary care physicians) and public health workers. We believe that our patients benefit from robust scientific data that are based on well conducted clinical trials. We also believe that basic sciences are the foundations on which we build our knowledge of clinical conditions and their management. Towards this end, although we are primarily a clinical based journal, we also welcome suitable basic sciences studies that promote our understanding of human hypertension. The journal aims to perform the dual role of increasing knowledge in the field of high blood pressure as well as improving the standard of care of patients. The editors will consider for publication all suitable papers dealing directly or indirectly with clinical aspects of hypertension, including but not limited to epidemiology, pathophysiology, therapeutics and basic sciences involving human subjects or tissues. We also consider papers from all specialties such as ophthalmology, cardiology, nephrology, obstetrics and stroke medicine that deal with the various aspects of hypertension and its complications.
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine29.7%
- Cardiovascular Health and Disease PreventionMedicine9.7%
- Heart Rate Variability and Autonomic ControlMedicine8.7%
- Sodium Intake and HealthNursing7.7%
- Hormonal Regulation and HypertensionMedicine7.2%
- Nutritional Studies and DietMedicine4.8%
- Renin-Angiotensin System StudiesMedicine2.8%
- Birth, Development, and HealthMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINECurrent ContentsPublisher website
Other: Google Scholar, EBSCO, OCLC, EBSO Discovery Service, EBSCO Academic Search, EBSCO Advanced Placement Source, EBSCO Biomedical Reference Collection, EBSCO Food Science Source, EBSCO STM Source, EBSCO TOC Premier
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.28LetPub ·
- Impact factor (publisher) 2025
- 3.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 3Publisher website ·
- CiteScore 2026-06
- 6.9LetPub ·
- SJR 2026-06
- 1.11LetPub ·
- SJR (publisher) 2025
- 1.11Publisher website ·
- SNIP 2026-06
- 1.24LetPub ·
- SNIP (publisher) 2025
- 1.24Publisher website ·
- h-index
- 91LetPub ·
- h-index
- 128OpenAlex ·
- i10-index
- 2,557OpenAlex ·
- 2-year mean citedness
- 2.36OpenAlex ·
- Self-citation rate
- 3%LetPub ·
- Share of gold OA articles
- 40.15%LetPub ·
Volume
- Articles per year
- 107LetPub ·
- Downloads per year (publisher) 2025
- 1,160,469Publisher website ·
Articles by year OpenAlex count · 4,334 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 124 | 54 | 28 |
| 2025 | 126 | 53 | 235 |
| 2024 | 98 | 50 | 558 |
| 2023 | 89 | 44 | 841 |
| 2022 | 148 | 74 | 2,235 |
| 2021 | 182 | 66 | 2,211 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
129 daysMedian, submission to acceptance · P25–P75 88 days – 205 days
- Acceptance to online
- median 11 days (105 articles)
- Submission to online
- median 147 days
- Sample
- 105 articles with submission and acceptance dates (270 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision 2025
- 20 daysPublisher website ·
- Submission to acceptance 2025
- 129 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 3,790 / GBP 2,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access
RSS feed available for table of contents updates Model summary
Journal of Human Hypertension now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1997
- ISSN
- 0950-9240
- Electronic ISSN
- 1476-5527
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Human Hypertension
What CAS zone is Journal of Human Hypertension in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Human Hypertension is in Zone 4 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Human Hypertension?
The latest impact factor listed by LetPub is 3.28; CiteScore 6.9, h-index 128.
How long does peer review take at Journal of Human Hypertension?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 129 days (interquartile range 88–205 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Human Hypertension?
According to LetPub and DOAJ records, Journal of Human Hypertension is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and Current Contents; that list has not been checked against each database.
Is Journal of Human Hypertension open access, and what is the APC?
Journal of Human Hypertension is a hybrid journal. For open-access publication: APC about USD 4,790.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .